EQRx to Hold First Quarter 2022 Financial Results Conference Call on Friday, May 13, 2022
April 29 2022 - 8:00AM
EQRx, Inc. (Nasdaq: EQRX), a new type of pharmaceutical company
committed to developing and delivering innovative medicines to
patients at radically lower prices, today announced it will host a
conference call and webcast on Friday, May 13, 2022 at 8:00 a.m. ET
to report its first quarter 2022 financial results and provide a
business update.
A live webcast can be accessed by visiting the
Investors section of the Company’s website at investors.eqrx.com.
The conference call can be accessed by dialing 855-718-8094
(domestic) or 484-747-6788 (international) and referring to
conference ID 6893121. The webcast will be made available for
replay on the Company’s website beginning approximately two hours
after the event.
About EQRxEQRx is a new type of
pharmaceutical company committed to developing and delivering
innovative medicines to patients at radically lower prices.
Launched in January 2020, EQRx is purpose-built, at scale, with a
growing catalog of medicines in development in high-cost drug
categories and emerging partnerships with leading payers and
providers. Leveraging cutting-edge science and technology and
strategic partnerships with stakeholders from across the healthcare
system, EQRx aims to provide innovative, patent-protected medicines
more efficiently and cost-effectively than ever before. To learn
more, visit www.eqrx.com and follow us on social media:
Twitter: @EQRxInc, LinkedIn,
Instagram: @eqrxinc.
EQRx™ and Remaking Medicine™ are trademarks of
EQRx.
EQRx Contacts:
Media:Dan Budwick1ABdan@1abmedia.com
Investors:investors@eqrx.com
EQRx (NASDAQ:EQRX)
Historical Stock Chart
From Mar 2024 to Apr 2024
EQRx (NASDAQ:EQRX)
Historical Stock Chart
From Apr 2023 to Apr 2024